Cargando…
Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation
Autores principales: | Koudriavtseva, Tatiana, Mainero, Caterina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865512/ https://www.ncbi.nlm.nih.gov/pubmed/27242489 http://dx.doi.org/10.3389/fnhum.2016.00226 |
Ejemplares similares
-
Neuroinflammation, neurodegeneration and regeneration in multiple sclerosis: intercorrelated manifestations of the immune response
por: Koudriavtseva, Tatiana, et al.
Publicado: (2016) -
Concurrence of Multiple Sclerosis and Brain Tumors
por: Plantone, Domenico, et al.
Publicado: (2015) -
Demyelinating and Thrombotic Diseases of the Central Nervous System: Common Pathogenic and Triggering Factors
por: Koudriavtseva, Tatiana, et al.
Publicado: (2015) -
Thrombotic Processes in Multiple Sclerosis as Manifestation of Innate Immune Activation
por: Koudriavtseva, Tatiana
Publicado: (2014) -
Cortical and white matter lesion topology influences focal corpus callosum atrophy in multiple sclerosis
por: Platten, Michael, et al.
Publicado: (2022)